Cellectis S.A Total Assets 2015-2020 | CLLS

Cellectis S.A total assets from 2015 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cellectis S.A Annual Total Assets
(Millions of US $)
2019 $467
2018 $501
2017 $333
2016 $331
2015 $379
2014 $183
Cellectis S.A Quarterly Total Assets
(Millions of US $)
2020-06-30 $473
2020-03-31 $471
2019-12-31 $467
2019-09-30 $480
2019-06-30 $505
2019-03-31 $512
2018-12-31 $501
2018-09-30 $520
2018-06-30 $534
2018-03-31 $324
2017-12-31 $333
2017-09-30 $349
2017-06-30 $316
2017-03-31 $325
2016-12-31 $331
2016-09-30 $351
2016-06-30 $364
2016-03-31 $347
2015-12-31 $379
2015-09-30 $336
2015-06-30 $340
2015-03-31 $383
2014-12-31 $183
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.861B $0.023B
Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.111B 15.76
Bristol Myers Squibb (BMY) United States $134.517B 10.36
CSL (CSLLY) Australia $96.728B 0.00
Gilead Sciences (GILD) United States $82.307B 11.85
Vertex Pharmaceuticals (VRTX) United States $69.688B 38.89
Regeneron Pharmaceuticals (REGN) United States $60.553B 23.16
Illumina (ILMN) United States $47.081B 54.75
Biogen (BIIB) United States $43.756B 7.49
Seattle Genetics (SGEN) United States $30.731B 0.00
Moderna (MRNA) United States $27.163B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.549B 10.65
Genmab (GMAB) Denmark $24.398B 15.41
Genmab (GNMSF) Denmark $23.229B 5.35
BeiGene (BGNE) Cayman Islands $22.973B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.904B 0.00
Immunomedics (IMMU) United States $19.730B 0.00
Incyte (INCY) United States $19.670B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.061B 37.58
Alnylam Pharmaceuticals (ALNY) United States $15.225B 0.00
BioNTech SE (BNTX) Germany $14.942B 0.00
Bio-Rad Laboratories (BIO.B) United States $14.252B 64.46
BioMarin Pharmaceutical (BMRN) United States $13.717B 99.53
Exact Sciences (EXAS) United States $11.414B 0.00
QIAGEN (QGEN) Netherlands $11.410B 28.96
Sarepta Therapeutics (SRPT) United States $11.301B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.250B 0.00
Guardant Health (GH) United States $10.231B 0.00
Bio-Techne Corp (TECH) United States $9.431B 64.71
Galapagos (GLPG) Belgium $8.943B 32.40
Exelixis (EXEL) United States $8.229B 29.92
Repligen (RGEN) United States $7.726B 122.63
Ascendis Pharma (ASND) Denmark $7.664B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.424B 18.47
Novavax (NVAX) United States $7.361B 0.00
Mirati Therapeutics (MRTX) United States $7.241B 0.00
MyoKardia (MYOK) United States $6.913B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.234B 0.00
Adaptive Biotechnologies (ADPT) United States $6.211B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.181B 0.00
Acceleron Pharma (XLRN) United States $6.063B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.009B 186.15
Emergent Biosolutions (EBS) United States $5.416B 21.45
Ultragenyx Pharmaceutical (RARE) United States $4.993B 0.00
Zai Lab (ZLAB) China $4.800B 0.00
MorphoSys AG (MOR) Germany $4.363B 57.17
China Biologic Products (CBPO) China $4.322B 25.66
Blueprint Medicines (BPMC) United States $4.200B 0.00
Legend Biotech (LEGN) United States $4.193B 0.00
Vir Biotechnology (VIR) United States $4.188B 0.00
Denali Therapeutics (DNLI) United States $4.054B 0.00
Arena Pharmaceuticals (ARNA) United States $4.030B 0.00
NeoGenomics (NEO) United States $3.917B 1182.33
Halozyme Therapeutics (HALO) United States $3.831B 0.00
Bluebird Bio (BLUE) United States $3.619B 0.00
Amicus Therapeutics (FOLD) United States $3.618B 0.00
Reata Pharmaceuticals (RETA) United States $3.536B 0.00
Insmed (INSM) United States $3.501B 0.00
Global Blood Therapeutics (GBT) United States $3.360B 0.00
Principia Biopharma (PRNB) United States $3.321B 0.00
Fate Therapeutics (FATE) United States $3.207B 0.00
Inovio Pharmaceuticals (INO) United States $3.102B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.912B 0.00
Alkermes (ALKS) Ireland $2.844B 59.60
Twist Bioscience (TWST) United States $2.812B 0.00
Revance Therapeutics (RVNC) United States $2.261B 0.00
PHARMA MAR SA (PHMMF) Spain $2.214B 0.00
Mesoblast (MESO) Australia $2.107B 0.00
I-Mab (IMAB) China $2.100B 0.00
Seres Therapeutics (MCRB) United States $2.084B 0.00
Editas Medicine (EDIT) United States $2.069B 0.00
Intra-Cellular Therapies (ITCI) United States $2.068B 0.00
Sorrento Therapeutics (SRNE) United States $2.023B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Eidos Therapeutics (EIDX) United States $1.897B 0.00
Zymeworks (ZYME) Canada $1.894B 0.00
UniQure (QURE) Netherlands $1.878B 0.00
Viela Bio (VIE) United States $1.851B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.842B 0.00
Mersana Therapeutics (MRSN) United States $1.758B 0.00
Amarin (AMRN) Ireland $1.611B 0.00
Cytokineticsorporated (CYTK) United States $1.571B 0.00
Ligand Pharmaceuticals (LGND) United States $1.530B 51.73
Sangamo Therapeutics (SGMO) United States $1.494B 0.00
Beam Therapeutics (BEAM) United States $1.489B 0.00
Zealand Pharma (ZEAL) Denmark $1.463B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.457B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.403B 0.00
Arcus Biosciences (RCUS) United States $1.402B 0.00
Coherus BioSciences (CHRS) United States $1.353B 7.89
Intellia Therapeutics (NTLA) United States $1.349B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
NGM Biopharmaceuticals (NGM) United States $1.323B 0.00
Epizyme (EPZM) United States $1.295B 0.00
Compugen (CGEN) Israel $1.223B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.134B 0.00
Alector (ALEC) United States $1.121B 0.00
REGENXBIO (RGNX) United States $1.112B 0.00
Alcobra (ARCT) United States $1.093B 0.00
Arvinas (ARVN) United States $1.073B 0.00
Athenex (ATNX) United States $1.067B 0.00
Adverum Biotechnologies (ADVM) United States $1.036B 0.00
Retrophin (RTRX) United States $1.013B 0.00
Myriad Genetics (MYGN) United States $0.974B 0.00
Pliant Therapeutics (PLRX) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.946B 0.00
Agenus (AGEN) United States $0.937B 0.00
Heska (HSKA) United States $0.926B 0.00
Intrexon (PGEN) United States $0.893B 0.00
NantKwest (NK) United States $0.886B 0.00
Morphic Holding (MORF) United States $0.870B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
Vericel (VCEL) United States $0.857B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Frequency Therapeutics (FREQ) United States $0.820B 0.00
Protagonist Therapeutics (PTGX) United States $0.778B 0.00
Kadmon Holdings (KDMN) United States $0.772B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
Codexis (CDXS) United States $0.729B 0.00
MiMedx (MDXG) United States $0.710B 0.00
Cara Therapeutics (CARA) United States $0.708B 0.00
Northwest Biotherapeutics (NWBO) United States $0.695B 0.00
Clovis Oncology (CLVS) United States $0.680B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.674B 0.00
WAVE Life Sciences (WVE) Singapore $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
AC Immune SA (ACIU) Switzerland $0.634B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.627B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.627B 0.00
Albireo Pharma (ALBO) United States $0.597B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Dynavax Technologies (DVAX) United States $0.592B 0.00
Geron (GERN) United States $0.562B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.557B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.530B 4.64
Anika Therapeutics (ANIK) United States $0.527B 23.03
Scholar Rock Holding (SRRK) United States $0.522B 0.00
IVERIC Bio (ISEE) United States $0.522B 0.00
Cue Biopharma (CUE) United States $0.519B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.511B 0.00
MeiraGTx Holdings (MGTX) United States $0.509B 0.00
Cel-Sci (CVM) United States $0.494B 0.00
Forte Biosciences (FBRX) United States $0.490B 0.00
Kala Pharmaceuticals (KALA) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.463B 0.00
Celldex Therapeutics (CLDX) United States $0.459B 0.00
Starpharma Holdings (SPHRY) Australia $0.455B 0.00
Amryt Pharma (AMYT) United Kingdom $0.443B 0.00
Avid Bioservices (CDMO) United States $0.442B 0.00
MannKind (MNKD) United States $0.438B 0.00
Pfenex (PFNX) United States $0.435B 0.00
Prothena (PRTA) Ireland $0.433B 0.00
AnaptysBio (ANAB) United States $0.430B 0.00
Athersys (ATHX) United States $0.422B 0.00
BioDelivery Sciences (BDSI) United States $0.405B 28.64
Puma Biotechnology (PBYI) United States $0.398B 0.00
Sutro Biopharma (STRO) United States $0.395B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.391B 0.00
Fortress Biotech (FBIO) United States $0.388B 0.00
Kamada (KMDA) Israel $0.387B 18.49
PDL BioPharma (PDLI) United States $0.375B 0.00
IBio (IBIO) United States $0.375B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.363B 8.57
Cellular Biomedicine (CBMG) United States $0.359B 0.00
Merus (MRUS) Netherlands $0.345B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.336B 0.00
Innate Pharma S.A (IPHA) France $0.328B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Prometic Life Sciences (LMNL) Canada $0.297B 0.00
Trevena (TRVN) United States $0.292B 0.00
Menlo Therapeutics (VYNE) United States $0.288B 0.00
Selecta Biosciences (SELB) United States $0.281B 0.00
ChromaDex (CDXC) United States $0.279B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.265B 0.00
Cyclerion Therapeutics (CYCN) United States $0.264B 0.00
OSMOTICA PHARM (OSMT) United States $0.258B 0.00
Checkpoint Therapeutics (CKPT) United States $0.255B 0.00
NextCure (NXTC) United States $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.252B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
Arbutus Biopharma (ABUS) United States $0.240B 0.00
Verastem (VSTM) United States $0.234B 0.00
TELA Bio (TELA) United States $0.232B 0.00
XOMA (XOMA) United States $0.227B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
DBV Technologies S.A (DBVT) France $0.220B 0.00
Dyadic (DYAI) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.212B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.207B 0.00
Kindred Biosciences (KIN) United States $0.200B 0.00
Cerecor (CERC) United States $0.200B 0.00
Biofrontera AG (BFRA) Germany $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.179B 0.00
Theratechnologies (THTX) Canada $0.179B 0.00
Exicure (XCUR) United States $0.178B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.178B 8.30
Aptinyx (APTX) United States $0.162B 0.00
Eton Pharmaceuticals (ETON) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.153B 0.00
Strongbridge Biopharma (SBBP) United States $0.152B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.151B 0.00
Aytu Bioscience (AYTU) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
VTv Therapeutics (VTVT) United States $0.145B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Bellus Health (BLU) Canada $0.142B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Cidara Therapeutics (CDTX) United States $0.139B 0.00
Cardiff Oncology (CRDF) United States $0.135B 0.00
AquaBounty Technologies (AQB) United States $0.134B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
SESEN BIO, INC (SESN) United States $0.125B 0.00
Gritstone Oncology (GRTS) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
Palatin Technologies (PTN) United States $0.116B 2.98
Windtree Therapeutics (WINT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.111B 0.00
Catalyst Biosciences (CBIO) United States $0.109B 0.00
Unum Therapeutics (UMRX) United States $0.108B 0.00
Vaccinex (VCNX) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.105B 5.34
PHASEBIO PHARMA (PHAS) United States $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Oncobiologics (OTLK) United States $0.086B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Ecology Coatings (ABVC) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
AmpliPhi Biosciences (ARMP) United States $0.068B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Evogene (EVGN) Israel $0.064B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
TRACON Pharmaceuticals (TCON) United States $0.062B 0.00
Curis (CRIS) United States $0.060B 0.00
Soligenix (SNGX) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.057B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 75.50
Genetic Technologies (GENE) Australia $0.052B 0.00
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Novogen (KZIA) Australia $0.051B 0.00
Organovo Holdings (ONVO) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
CollPlant Holdings (CLGN) Israel $0.050B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.048B 0.00
Signal Genetics (MGEN) United States $0.048B 0.00
IMMURON (IMRN) Australia $0.046B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
OvaScience (MLND) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Acorda Therapeutics (ACOR) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
Spherix (AIKI) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00